---
$id: https://graph.org.ai/products/commodity/51151658
$type: Product
source: UNSPSC
code: "51151658"
title: "Oxyphenonium"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Oxyphenonium

**UNSPSC Code**: 51151658
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent with the molecular formula C21H34NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D2G5508Y7I, chemically known as ethanaminium, 2-((cyclohexylhydroxyphenylacetyl)oxy)-n,n-diethyl-n-methyl- but generally known as oxyphenonium, which bears US NIH Compound Identifier 5749. European Medicines Agency schedules Oxyphenonium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14736MIG. World Health Organization schedules oxyphenonium in its Anatomical Therapeutic Chemical (ATC) Classification. OXYPHENONIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, OXYPHENONIUM remains the US FDA Preferred Term for this commodity. Oxyphenonium bears US NLM identifiers UMLS ID C0030082 and NCI Concept Code C78076. SMILES: OC(C1CCCCC1)(C1CCCCC1)C(=O)OCC[N](CC)(CC)C. .

